Knight Therapeutics Inc.
KHTRF
$6.59
$0.111.70%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 521.98% | -17.18% | -4,517.98% | -542.81% | 145.15% |
| Total Depreciation and Amortization | 44.25% | 8.53% | 31.41% | -8.84% | -13.50% |
| Total Amortization of Deferred Charges | -- | 6.37% | -- | -- | -- |
| Total Other Non-Cash Items | 126.92% | 91.98% | 195.90% | 2,111.75% | -81.72% |
| Change in Net Operating Assets | 173.35% | 197.22% | -2.58% | 207.65% | -169.83% |
| Cash from Operations | 1,044.33% | 2,283.63% | 100.64% | 1,944.21% | -88.84% |
| Capital Expenditure | -820.24% | 9.45% | -8.57% | 10.88% | 61.41% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -51.40% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -56.11% | -122.13% | -81.69% | -50.61% | 229.71% |
| Cash from Investing | -66.33% | -125.50% | -112.08% | -952.38% | 223.86% |
| Total Debt Issued | -- | 59.67% | -- | 14,544.44% | 231.93% |
| Total Debt Repaid | -362.89% | -274.70% | -65.02% | -606.28% | -3.72% |
| Issuance of Common Stock | -1.75% | -5.00% | -71.88% | 6.76% | 54.05% |
| Repurchase of Common Stock | -146.25% | 41.73% | -- | 99.52% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.06% | -1.03% | -103.78% | 7.19% | 37.13% |
| Cash from Financing | -368.00% | -127.57% | -49.01% | 542.29% | -52.37% |
| Foreign Exchange rate Adjustments | 87.77% | -142.10% | 261.54% | -204.85% | 96.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.75% | -185.80% | -68.95% | -1,574.59% | 639.00% |